Select Bibliography

Select Bibliography

Filter by any of these (after searching):

Federally Funded Research

There are 235 items

A phase II second-line study of pemetrexed (pem) in combination with bevacizumab (bev) in patients with advanced non-small cell lung cancer (NSCLC): An NCCTG and SWOG study.

Google Scholar

Adjei, A. A. , Mandrekar, S. J. , Dy, G. K. , Molina, J. R. ... - - J. Clin. Oncol. - 2008

Abstract - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0426

Phase II trial of pemetrexed plus bevacizumab for second-line therapy of patients with advanced non-small-cell lung cancer: NCCTG and SWOG study N0426

PubMed

PMC

QxMD

Google Scholar

Adjei, A. A. , Mandrekar, S. J. , Dy, G. K. , Molina, J. R. ... - - J. Clin. Oncol. - 2010

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0426

A front-line window of opportunity phase II study of sorafenib in patients with advanced non-small cell lung cancer.

Google Scholar

Adjei, A. A. , Molina, J. R. , Hillman, S. L. , Luyun, R. F. ... - - J. Clin. Oncol. - 2007

Abstract - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0326

Correlation between polymorphisms in the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer (NSCLC): An NCCTG N0026 based study. Abstract 198.

Google Scholar

Adjei, A. , Salavaggione, O. , Mandrekar, S. , Dy, G. ... - NCI TSM - - 2009

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - NCCTG-N0026

Correlation between polymorphisms of the reduced folate carrier gene (SLC19A1) and survival after pemetrexed-based therapy in non-small cell lung cancer: a North Central Cancer Treatment Group-based exploratory study.

PubMed

PMC

QxMD

DOI

Google Scholar

Adjei, Araba A , Salavaggione, Oreste E , Mandrekar, Sumithra J ... - - J Thorac Oncol - 2010

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - N0026

ACOSOG Z0030 Study Group: Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective ACOSOG Z0030 trial

Google Scholar

Allen, M. S. , Darling, G. E. , Decker, P. A. , Putnam, J. B. Jr ... - - J. Clin. Oncol. - 2007

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

PubMed

PMC

QxMD

DOI

Google Scholar

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - - Lancet Respir Med - 2018

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0010

Perioperative mortality and Morbidity after Lobar versus Sublobar Resection for early stage lung cancer: A post-hoc analysis of an international randomized phase III trial (CALGB/Alliance 140503)

PubMed

PMC

QxMD

DOI

Google Scholar

Altorki, Nasser K. , Wang, Xiaofei , Wigle, Dennis , Gu, Lin ... - AATS - Lancet Respir Med - 2018

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-140503

Exploring the statistical and clinical impact of two interim analyses on the phase II design with option for direct assignment

PubMed

PMC

QxMD

DOI

Google Scholar

An, Ming-Wen , Mandrekar, Sumithra J. , Edelman, Martin J. ... - - Contemp Clin Trials - 2014

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-30203

Maintenance Sunitinib following Initial Platinum-Based Combination Chemotherapy in Advanced-Stage IIIB/IV Non–Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase III Study—CALGB 30607 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Baggstrom, Maria Q. , Socinski, Mark A. , Wang, Xiaofei F. , Gu, Lin ... - - J Thorac Oncol - 2017

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30607 , CALGB-70701

Induction (Ind) plus concurrent (Con) chemotherapy with high-dose (74 Gy) 3-dimensional (3-D) thoracic radiotherapy (TRT) in stage III non-small cell lung cancer (NSCLC): Preliminary report of Cancer and Leukemia Group B (CALGB) 30105

Google Scholar

Blackstock, A. W. , Socinski, M. A. , Bogart, J. , Gu, L. , Wang, X. ... - - J. Clin. Oncol. - 2006

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30105

Accelerated conformal radiotherapy for stage I non-small cell lung cancer (NSCLC) in patients with pulmonary dysfunction: A CALGB phase I study.

Google Scholar

Bogart, J. , Watson, D. , Seagren, S. , Blackstock, W. , Wang, X. ... - - J. Clin. Oncol. - 2007

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39904

Phase I Study of Accelerated Conformal Radiotherapy for Stage I Non–Small-Cell Lung Cancer in Patients With Pulmonary Dysfunction: CALGB 39904

PubMed

PMC

QxMD

DOI

Google Scholar

Bogart, Jeffrey A. , Hodgson, Lydia , Seagren, Stephen L. ... - - J Clin Oncol - 2010

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39904

Interruptions Of Once-Daily Thoracic Radiotherapy Do Not Correlate With Outcomes In Limited Stage Small Cell Lung Cancer: Analysis of CALGB Phase III Trial 9235

PubMed

PMC

QxMD

DOI

Google Scholar

Bogart, Jeffrey A. , Watson, Dorothy , McClay, Edward F. ... - - Lung Cancer - 2008

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-9235

Detection of human telomerase reverse transcriptase mRNA in cells obtained by lavage of the pleura is not associated with worse outcome in patients with stage I/II non-small cell lung cancer; Results from CALGB 159902

PubMed

PMC

QxMD

DOI

Google Scholar

Boylan, Alice M. , Wang, Xiaofei F , Ko, Richard , Watson, Patricia M ... - - J. Thorac. Cardiovasc. Surg. - 2013

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-159902

LACE-Bio: validation of prognostic role of tumour lymphocytic infiltration in resectable non small cell lung cancer

Google Scholar

Brambilla, E. , Domerg, C. , Lantuejoul, S. , Kratzke, R. ... - - J Thorac Oncol - 2012

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

LACE-Bio: results of pooled analysis of prognostic and predictive values of histology and lymphocytic infiltration

Google Scholar

Brambilla, E. , Tsao, M. , Paris, E. , Lantuejoul, S. ... - - Ann. Oncol. - 2010

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Brambilla, Elisabeth , Le Teuff, Gwénaël , Marguet, Sophie ... - - J. Clin. Oncol - 2016

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-9633

Phase II Trial of Oral Topotecan and Intravenous Carboplatin With G-CSF Support in Previously Untreated Patients With Extensive Stage Small Cell Lung Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Bryce, Alan H. , Mattar, Bassam , Hillman, Shauna L. , Adjei, Alex A. ... - - Am. J. Clin. Oncol. - 2010

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-0027

Phase 2 Trial of Pemetrexed Disodium and Carboplatin in Previously Untreated Extensive-Stage Small Cell Lung Cancer, N0423

PubMed

PMC

QxMD

DOI

Google Scholar

Chee, Cheng E. , Jett, James R. , Bernath, Albert M. ... - - Cancer - 2010

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0423

A pooled exploratory analysis of the effect of tumor size on survival benefit from adjuvant platinum-based chemotherapy (ACT) in node negative (N0) non-small cell lung cancer (NSCLC)

Google Scholar

Cuffe, S. , Ezzalfani, M. , Bourredjem, A. , Graziano, S. L. ... - Chicago MSTO - - 2010

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633

A Pooled Exploratory Analysis of the Impact of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy (ACT) in Node Negative (N0) Non-Small Cell Lung Cancer (NSCLC).

Google Scholar

Cuffe, S. , Graziano, S. , Bourredjem, A. , Pignon, J. P. ... - - J Thorac Oncol - 2011

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633

A Pooled Exploratory Analysis of the Effect of Tumor Size and KRAS Mutations on Survival Benefit from Adjuvant Platinum-Based Chemotherapy in Node Negative Non-Small Cell Lung Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Cuffe, Sinead , Bourredjem, Abderrahmane , Graziano, Stephen ... - - J Thorac Oncol - 2012

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

The impact of occult micrometastases on survival following resection of stage I non-small cell lung cancer: Final analysis of CALGB 9761

Google Scholar

D'Cunha, J. , Wang, X. , Groth, S. S. , Vollmer, R. T. ... - IASLC (WCLC) - J Thorac Oncol - 2009

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9761

Randomized Trial of Mediastinal Lymph Node Sampling versus Complete Lymphadenectomy During Pulmonary Resection in Patients with N0 or N1 (Less than Hilar) Non-Small Cell Carcinoma: Results of the ACOSOG Z0030 Trial

Google Scholar

Darling, G. , Allen, M. , Decker, P. , Ballman, K. , Landreneau, R. ... - AATS - American Association for Thoracic Oncology 90th Annual Meeting, Toronto, ON, Canada - 2010

Abstract - Primary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Number of Lymph Nodes Harvested From a Mediastinal Lymphadenectomy

PubMed

PMC

QxMD

DOI

Google Scholar

Darling, Gail E. , Allen, Mark S. , Decker, Paul A. , Ballman, Karla ... - - Chest - 2011

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Randomized Trial of Mediastinal Lymph Node Sampling Versus Complete Lymphadenectomy During Pulmonary Resection in the Patient with N0 or N1 (Less Than Hilar) Non-Small Cell Carcinoma: Results of the ACOSOG Z0030 Trial

PubMed

PMC

QxMD

DOI

Google Scholar

Darling, Gail E. , Allen, Mark S. , Decker, Paul A. , Ballman, Karla ... - - J. Thorac. Cardiovasc. Surg. - 2011

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

In-dwelling catheters are superior to talc pleurodesis in the management of malignant pleural effusions

Google Scholar

Demmy, T. L. , Gu, L. , Burkhalter, J. , Toloza, E. M. ... - - J. Clin. Oncol. - 2010

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30102

Hypothetical double-consent design intervention

Google Scholar

Demmy, T. L. , Kohman, L. J. ... - CTAS - - 2010

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-30102 , CALGB-9334

Optimal Management of Malignant Pleural Effusions (Results of CALGB 30102)

PubMed

PMC

QxMD

Google Scholar

Demmy, Todd L. , Gu, Lin , Burkhalter, Jack E. , Toloza, Eric M. ... - - J Natl Compr Canc Netw - 2012

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30102

Impact of trial development time on accruals at CCOPs: The case of the MARVEL trial.

Google Scholar

Dilts, D. M. , Adjei, A. A. , Mandrekar, S. J. , Buckner, J. C. ... - - J. Clin. Oncol. - 2010

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - NCCTG-N0723

Sublobar Resection and Iodine-125 Brachytherapy for Stage 1 NSCLC, Initial Quality Assurance Review of ACOSOG Z-4032

Google Scholar

Dipetrillo, T. A. , Heron, D. E. , Landreneau, R. J. , Logan, D. ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2009

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

Phase III Intergroup Study of Talc Poudrage vs Talc Slurry Sclerosis for Malignant Pleural Effusion

PubMed

PMC

QxMD

DOI

Google Scholar

Dresler, Carolyn M. , Olak, Jemi , Herndon, James E. ... - - Chest - 2005

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9334

A phase II study of sorafenib in malignant mesothelioma: results of CALGB 30307

PubMed

PMC

QxMD

DOI

Google Scholar

Dubey, Sarita , Jänne, Pasi A. , Krug, Lee , Pang, Herbert ... - - J Thorac Oncol - 2010

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30307

CALGB 30601: A phase II study of dasatinib (D) in patients (pts) with previously treated malignant mesothelioma (MM)

Google Scholar

Dudek, A. Z. , Kindler, H. L. , Otterson, G. A. , Pang, H. ... - - J. Clin. Oncol. - 2010

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30601

Phase II study of dasatinib in patients with previously treated malignant mesothelioma (cancer and leukemia group B 30601): a brief report

PubMed

PMC

QxMD

Google Scholar

Dudek, A. Z. , Pang, H. , Kratzke, R. A. , Otterson, G. A. ... - - J Thorac Oncol - 2012

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30601

Randomized phase 2 study of maintenance pemetrexed versus observation for patients (pts) with malignant pleural mesothelioma (MPM) without progression after first-line chemotherapy: Cancer and Leukemia Group B (CALGB/Alliance) 30901

DOI

Google Scholar

Dudek, Arkadiusz Z. , Wang, Xiaofei , Gu, Lin , Stinchcombe, Thomas ... - ASCO - J Clin Oncol - 2019

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30901

Radiofrequency ablation of stage Ia NSCLC in medically inoperable patients: Results from ACOSOG Z4033 (Alliance) an NCI funded multicenter trial

DOI

Google Scholar

Dupuy, D. E. , Fernando, H. , Hillman, S. , Ng, T. , Tan, A. D. ... - CHEST - Chest - 2013

Abstract - Primary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4033

Radiofrequency Ablation of Stage IA NSCLC in Medically Inoperable Patients: Results from the ACOSOG Z4033 (Alliance) Trial

PubMed

PMC

QxMD

DOI

Google Scholar

Dupuy, Damian E. , Fernando, Hiran C. , Hillman, Shauna , Ng, Thomas ... - - Cancer - 2015

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4033

A randomized phase II study of gemcitabine (G) and carboplatin (C) with or without cediranib (AZD2171 [CED]) as first-line therapy in advanced non-small cell lung cancer (NSCLC).

Google Scholar

Dy, G. K. , Mandrekar, S. J. , Nelson, G. D. , Ross, H. J. ... - - J. Clin. Oncol. - 2010

Abstract - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0528

N0821: A phase II first-line study of a combination of pemetrexed (P), carboplatin (C), and bevacizumab (B) in elderly patients with good performance status (PS < 2)

Google Scholar

Dy, G. K. , Molina, J. , Qi, Y. , Ansari, R. H. , Thomas, S. ... - - J. Clin. Oncol. - 2012

Abstract - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0821

A Front-Line “Window of Opportunity” Phase II Study of Sorafenib in Patients with Advanced Non-small Cell Lung Cancer (NSCLC)– A North Central Cancer Treatment Group Study N03261

PubMed

PMC

QxMD

DOI

Google Scholar

Dy, Grace K. , Hillman, Shauna L. , Rowland, Kendrith M. ... - - Cancer - 2010

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0326

A Randomized Phase II Study of Gemcitabine and Carboplatin With or Without Cediranib as First-Line Therapy in Advanced Non-Small Cell Lung Cancer: North Central Cancer Treatment Group Study N0528

PubMed

PMC

QxMD

DOI

Google Scholar

Dy, Grace K. , Mandrekar, Sumithra J. , Nelson, Garth D. ... - - J Thorac Oncol - 2013

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0528

NCCTG N0821 (Alliance): A phase II first-line study of pemetrexed, carboplatin and bevacizumab in elderly patients with advanced nonsquamous non-small cell lung cancer with good performance status

PubMed

PMC

QxMD

DOI

Google Scholar

Dy, Grace K. , Molina, Julian R. , Qi, Yingwei , Ansari, Rafat ... - - J Thorac Oncol - 2014

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0821

Serum VEGF and COX-2/5LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304

Google Scholar

Edelman, M. J. , Hodgson, L. D. , Wang, X. , Christenson, R. H. ... - - J. Clin. Oncol. - 2010

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-150304

Eicosanoid modulation in advanced non-small cell lung cancer (NSCLC): CALGB 30203

Google Scholar

Edelman, M. J. , Watson, D. M. , Wang, X. , Kratzke, R. A. ... - - J. Clin. Oncol. - 2006

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30203

Serum Vascular Endothelial Growth Factor and COX-2/5-LOX Inhibition in Advanced Non-small Cell Lung Cancer: Cancer and Leukemia Group B 150304

PubMed

PMC

QxMD

DOI

Google Scholar

Edelman, Martin J. , Hodgson, Lydia , Wang, Xiaofei ... - - J Thorac Oncol - 2011

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-150304 , CALGB-30203

Final Results of a phase III trial of celecoxib (C) in addition to standard chemotherapy for advanced NSCLC with COX- 2 overexpression: CALGB 30801 (Alliance)

Google Scholar

Edelman, Martin J. , Wang, Xiaofei , Hodgson, Lydia ... - MSTO - Int. J. Radiat. Oncol. Biol. Phys. - 2017

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30801

Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Edelman, Martin J. , Wang, Xiaofei , Hodgson, Lydia ... - - J. Clin. Oncol - 2017

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30801

Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.

PubMed

DOI

Google Scholar

Edelman, Martin J , Watson, Dee , Wang, Xiaofei , Morrison, Carl ... - - J. Clin. Oncol. - 2008

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30203

Thirty and Ninety Day Outcomes After Sublobar Resection of High-risk Patients with Non-small cell lung cancer (NSCLC); Results from a multicenter phase III study

Google Scholar

Fernando, H. C. , Landreneau, R. J. , Mandraker, S. , Hillman, S. ... - AATS - American Association of Thoracic Surgery 91st Annual Meeting - 2011

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

The Impact of Adjuvant Brachytherapy with Sublobar Resection on Pulmonary Function and Dyspnea: Preliminary Results from ACOSOG Z4032 Trial

Google Scholar

Fernando, H. C. , Landreneau, R. , Mandraker, S. , Hillman, S. ... - AATS - American Association of Thoracic Surgery 90th Annual Meeting - 2010

Abstract - Primary Endpoint - Preliminary Analysis - Respiratory - ACOSOG-Z4032

Impact of brachytherapy on local recurrence after sublobar resection: Results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small cell lung cancer (NSCLC)

Google Scholar

Fernando, H. , Landreneau, R. , Mandrekar, S. , Nichols, F. ... - ASCO - J. Clin. Oncol. - 2013

Abstract - Primary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

Impact of Brachytherapy on Local Recurrence Rates After Sublobar Resection: Results From ACOSOG Z4032 (Alliance), a Phase III Randomized Trial for High-Risk Operable Non–Small-Cell Lung Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Fernando, Hiran C. , Landreneau, Rodney J. , Mandrekar, Sumithra J. ... - - J. Clin. Oncol - 2014

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: A randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non–small cell lung cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Fernando, Hiran C. ... - - J. Thorac. Cardiovasc. Surg. - 2012

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Respiratory - ACOSOG-Z4099

The Impact of Adjuvant Brachytherapy with Sublobar Resection on Pulmonary Function and Dyspnea in High-risk Operable Patients; Preliminary results from the ACOSOG Z4032 Trial

PubMed

PMC

QxMD

DOI

Google Scholar

Fernando, Hiran C , Landreneau, Rodney J , Mandrekar, Sumithra J ... - - J Thorac Cardiovasc Surg - 2011

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030)

Google Scholar

Fibla, J. J. , Cassivi, S. D. , Decker, P. A. , Allen, M. S. ... - - J. Clin. Oncol. - 2010

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Re-evaluation of the prognostic value of visceral pleura invasion in Stage IB non-small cell lung cancer using the prospective multicenter ACOSOG Z0030 trial data set

PubMed

PMC

QxMD

DOI

Google Scholar

Fibla, Juan J. , Cassivi, Stephen D. , Brunelli, Alessandro ... - - Lung Cancer - 2012

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Validation of the lung cancer staging system revisions using a large prospective clinical trial database (ACOSOG Z0030)

PubMed

PMC

QxMD

DOI

Google Scholar

Fibla, Juan J. , Cassivi, Stephen D. , Decker, Paul A. ... - - Eur J Cardiothorac Surg - 2013

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Age, Gender, Performance Status and Stage Outperformed Stage alone in Predicting Overall Survival (OS) in Patients with Small Cell Lung Cancer: A Pooled Analysis of 1623 patients from the North Central Cancer Treatment Group.

Google Scholar

Foster, N. R. , Mandrekar, S. J. , Schild, S. E. , Nelson, G. D. ... - - J. Clin. Oncol. - 2007

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - N0424

Prognostic importance of performance status (PS) in small cell lung cancer (SCLC): A North Central Cancer Treatment Group (NCCTG) investigation.

Google Scholar

Foster, N. R. , Mandrekar, S. J. , Schild, S. E. , Nelson, G. D. ... - - J. Clin. Oncol. - 2008

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - N0424

Comparison of progression-free survival (PFS) and tumor response as endpoints for predicting overall survival (OS) in untreated extensive-stage small cell lung cancer (ED-SCLC): Findings based on North Central Cancer Treatment Group (NCCTG) trials.

Google Scholar

Foster, N. R. , Qi, Y. , Krook, J. E. , Kugler, J. W. , Kuross, S. A. ... - - J. Clin. Oncol. - 2009

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - N0424

Tumor response and progression-free survival (PFS) as potential surrogate endpoints for overall survival (OS) in extensive-stage small cell lung cancer (ES-SCLC): Findings based on North Central Cancer Treatment Group (NCCTG) trials.

Google Scholar

Foster, N. R. , Qi, Y. , Shi, Q. , Krook, J. E. , Kugler, J. W. ... - - J. Clin. Oncol. - 2010

Abstract - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0424

Multitrial evaluation of progression-free survival (PFS) as a surrogate endpoint for overall survival (OS) in previously untreated extensive-stage small cell lung cancer (ES-SCLC): An Alliance-led analysis

Google Scholar

Foster, N. R. , Renfro, L. A. , Schild, S. E. , Redman, M. W. ... - - J. Clin. Oncol. - 2013

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - Comprehensive , CALGB-9033 , CALGB-9732 , CALGB-30103 , NCCTG-862051 , NCCTG-892051 , NCCTG-932053 , ECOG-1500 , ECOG-7593 , JCOG-9511 , NCIC-BR4 , NCIC-BR8 , SWOG-S0124

Prognostic factors differ by tumor stage for Small Cell Lung Cancer: A Pooled Analysis of North Central Cancer Treatment Group (NCCTG) Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Foster, Nathan R. , Mandrekar, Sumithra J. , Schild, Steven E. ... - - Cancer - 2009

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - N0424

Tumor Response and Progression-Free Survival as Potential Surrogate Endpoints for Overall Survival in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Findings Based on North Central Cancer Treatment Group (NCCTG) Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Foster, Nathan R. , Qi, Yingwei , Shi, Qian , Krook, James E. ... - - Cancer - 2011

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0424

Multi-Trial Evaluation of Progression-Free Survival (PFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

PubMed

PMC

QxMD

DOI

Google Scholar

Foster, Nathan R. , Renfro, Lindsay A. , Schild, Steven E. ... - - J Thorac Oncol - 2015

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-30103 , N0424 , NCCTG-932053

Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer.

PubMed

DOI

Google Scholar

Garces, Yolanda I , Okuno, Scott H , Schild, Steven E ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2007

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N9923

Phase II study of pemetrexed, carboplatin and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non-small cell lung cancer: CALGB 30407

Google Scholar

Govindan, R. , Bogart, J. A. , Wang, X. , Hodgson, L. D. ... - - J. Clin. Oncol. - 2009

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30407

A phase II study of pemetrexed, carboplatin and thoracic radiation with or without cetuximab in patients with locally advanced unresectable non small cell lung cancer: CALGB 30407 early evaluation of feasibility and toxicity

Google Scholar

Govindan, R. , Bogart, J. A. , Wang, X. , Liu, D. , Kratzke, R. A. ... - - J. Clin. Oncol. - 2008

Abstract - Primary Endpoint - Preliminary Analysis - Respiratory - CALGB-30407

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407

PubMed

PMC

QxMD

DOI

Google Scholar

Govindan, Ramaswamy , Bogart, Jeffrey , Stinchcombe, Thomas ... - - J Clin Oncol - 2011

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30407

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early Stage Non–Small Cell Lung Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Govindan, Ramaswamy , Mandrekar, Sumithra J. , Gerber, David E. ... - - Clin. Cancer Res. - 2015

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Respiratory - A151216

A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.

PubMed

DOI

Google Scholar

Govindan, Ramaswamy , Wang, Xiaofei , Baggstrom, Maria Q ... - - J Thorac Oncol - 2009

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30104

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer (NSCLC) treated with adjuvant chemotherapy: Results from IALT, JBR.10 and ANITA

Google Scholar

Graziano, S. L. , Pignon, J. P. , Vollmer, R. T. , Kratzke, R. A. ... - IASLC (WCLC) - J Thorac Oncol - 2009

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

Dose-dense weekly paclitaxel (P) in extensive stage small cell lung cancer (ES-SCLC): Cancer and Leukemia Group B (CALGB) 39901

Google Scholar

Graziano, S. L. , Socinski, M. A. , Herndon, J. E., 2nd ... - - Proc Am Soc Clin Oncol - 2003

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39901

LACE-Bio pooled analysis of the prognostic and predictive value of p53 mutations and expression by Immunohistochemistry (IHC) in patients with resected Non-Small Cell Lung Cancer (NSCLC).

Google Scholar

Graziano, S. , Paris, E. , Ma, X. , Pignon, J. , Hainaut, P. ... - - Ann. Oncol. - 2010

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633

Prognostic Significance of Mucin and p53 Expression in Stage IB Non-Small Cell Lung Cancer: A Laboratory Companion Study to CALGB 9633

PubMed

PMC

QxMD

Google Scholar

Graziano, Stephen L. , Gu, Lin , Wang, Xiaofei , Tatum, Arthur H. ... - - J Thorac Oncol - 2010

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-9633

Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITA

PubMed

PMC

QxMD

DOI

Google Scholar

Graziano, Stephen L. , Lacas, Benjamin , Vollmer, Robin ... - - Lung Cancer - 2013

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633

Phase II trial of weekly dose-dense paclitaxel in extensive-stage small cell lung cancer: cancer and leukemia group B study 39901.

PubMed

DOI

Google Scholar

Graziano, Stephen L , Herndon, James E , Socinski, Mark A ... - - J Thorac Oncol - 2008

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39901

Phase II randomized study of dose-dense docetaxel (Doc) and cisplatin (Cis) every two weeks with pegfilgrastim (Pfil) and darbepoetin alfa (Darb) with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (NSCLC)

Google Scholar

Green, M. R. , Miller, A. A. , Wang, X. , Gu, L. ... - - J. Clin. Oncol. - 2007

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30303

Accuracy of FDG-PET to diagnose lung cancer in the ACOSOG Z4031 trial

Google Scholar

Grogan, E. , Deppen, S. , Ballman, K. , Andrade, G. , Verdail, F. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4031

Accuracy of FDG-PET within the clinical practice of the ACOSOG Z4031 trial to diagnose clinical stage I NSCLC

PubMed

PMC

QxMD

DOI

Google Scholar

Grogan, Eric L. , Deppen, Stephen A. , Ballman, Karla V. ... - - Ann. Thorac. Surg. - 2014

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4031

LACE-Bio Pooled Analysis of the Prognostic and Predictive Value of TP53 mutations in Completely Resected Non Small Cell Lung Cancer (NSCLC)

Google Scholar

Hainaut, P. , Ma, X. , Lacas, B. , Tsao, M. , Douillard, J.-Y. ... - ESMO - - 2012

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633

Proteomic analysis for detection of NSCLC: Results of ACOSOG Z4031

Google Scholar

Harpole, D. , Ballman, K. V. , Oberg, A. L. , Whiteley, G. ... - - J. Clin. Oncol. - 2011

Abstract - Primary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4031

CALGB 30704: A randomized phase II study to assess the efficacy of pemetrexed or sunitinib or pemetrexed plus sunitinib in the second-line treatment of advanced non-small cell lung cancer (NSCLC)

Google Scholar

Heist, R. C. Suk , Wang, X. , Hodgson, L. D. , Otterson, G. A. ... - - J. Clin. Oncol. - 2012

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30704

A Randomized Phase II Study to Assess the Efficacy of Pemetrexed or Sunitinib or Pemetrexed Plus Sunitinib in the Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Heist, Rebecca S. , Wang, Xiaofei , Hodgson, Lydia ... - - J Thorac Oncol - 2014

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30704

Randomized multicenter phase II trial evaluating the sequencing of PD-1 inhibition with pembrolizumab (ppembro) and standard platinum-based chemotherapy (chemo) in patients (pts) with metastatic non-small cell lung cancer (NSCLC) AFT-09 (Alliance)

DOI

Google Scholar

Hensing, Thomas , Wang, Xiaofei , Kozono, David , Dudek, Arkadius ... - ASCO - J. Clin. Oncol. - 2019

Abstract - Primary Endpoint - Primary Analysis - Respiratory - AFT-09

Evaluation of the value of attribution in the interpretation of adverse event data: a North Central Cancer Treatment Group and American College of Surgeons Oncology Group investigation

PubMed

PMC

QxMD

Google Scholar

Hillman, S. L. , Mandrekar, S. J. , Bot, B. , Dematteo, R. P. ... - - J. Clin. Oncol. - 2010

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - ACOSOG-Z9001 , NCCTG-97-24-51

Vatalanib in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (CALGB 30107).

PubMed

PMC

QxMD

DOI

Google Scholar

Jahan, Thierry , Gu, Lin , Kratzke, Robert , Dudek, Arkadiusz ... - - Lung Cancer - 2012

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30107

Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: Results of CALGB Protocol 39803

PubMed

PMC

QxMD

Google Scholar

Jaklitsch, M. T. , Gu, L. , Demmy, T. , Harpole, D. H. ... - - J Thorac Cardiovasc Surg - 2013

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39803

Prospective Phase II Trial of Pre-Resection Thoracoscopic (VATS) Restaging Following Neoadjuvant Therapy For IIIA(N2) Non-small Cell Lung Cancer (NSCLC): Results of CALGB 39803

Google Scholar

Jaklitsch, M. T. , Gu, L. , Harpole, D. H. , D'Amico, T. A. ... - - J. Clin. Oncol. - 2005

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39803

Randomized phase II trial of erlotinib (E) alone or in combination with carboplatin/paclitaxel (CP) in never or light former smokers with advanced lung adenocarcinoma: CALGB 30406

Google Scholar

Janne, P. A. , Miller, V. A. , Wang, X. , Socinski, M. A. ... - - J. Clin. Oncol. - 2010

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30406

Sorafenib in malignant mesothelioma (MM): A phase II trial of the Cancer and Leukemia Group B (CALGB 30307)

Google Scholar

Janne, P. A. , Wang, X. F. , Krug, L. M. , Hodgson, L. , Vokes, E. E. ... - - J. Clin. Oncol. - 2007

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30307

Randomized Phase II Trial of Erlotinib Alone or With Carboplatin and Paclitaxel in Patients Who Were Never or Light Former Smokers With Advanced Lung Adenocarcinoma: CALGB 30406 Trial

PubMed

PMC

QxMD

Google Scholar

Janne, P. A. , Wang, X. F. , Socinski, M. A. , Crawford, J. ... - - J. Clin. Oncol. - 2012

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30406

Outcome of advanced NSCLC patients with EGFR exon 19 and 21 mutations treated with erlotinib (E) alone or in combination with carboplatin/paclitaxel (CP) in CALGB 30406

Google Scholar

Janne, P. A. , Wang, X. , Socinski, M. A. , Crawford, J. , Gu, L. ... - - J Thorac Oncol - 2011

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-30406

Prognostic and Predictive Values of KRAS in EGFR-based Subgroups and Combined with P53 in Completely Resected Non-Small Cell Lung Cancer (NSCLC): a LACE-Bio Study

Google Scholar

Janne, P. , Shepherd, F. , Domerg, C. , Le Teuff, G. , Kratzke, R. ... - - Ann. Oncol. - 2012

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

A phase II study of cetuximab and radiation in elderly and/or poor performance status patients with locally advanced non-small-cell lung cancer (N0422)

PubMed

PMC

QxMD

DOI

Google Scholar

Jatoi, A. , Schild, S. E. , Foster, N. , Henning, G. T. ... - - Ann Oncol - 2010

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0422

Is social support associated with improved clinical outcomes in geriatric lung cancer patients? Observations from North Central Cancer Treatment Group Studies N9921 and N0222

PubMed

PMC

QxMD

Google Scholar

Jatoi, Aminah , Hillman, Shauna L , Ziegler, Katie L Allen ... - - Cancer Manag Res - 2009

Manuscript - Secondary Endpoint - Comprehensive Analysis - Respiratory - N0222 , N9921

Phase II trial of pemetrexed (P) and carboplatin (C) in previously untreated extensive stage disease small cell lung cancer (ED-SCLC): A NCCTG Study

Google Scholar

Jett, J. R. , Bernath, A. Jr , Foster, N. , Molina, J. ... - - J. Clin. Oncol. - 2008

Abstract - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0423

Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).

PubMed

DOI

Google Scholar

Johnson, Elizabeth A , Marks, Randolph S , Mandrekar, Sumithra J ... - - Lung Cancer - 2008

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-972451

Peak Oxygen Consumption and Long-Term All-Cause Mortality in Non-Small Cell Lung Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Jones, Lee W. , Watson, Dorothy , Herndon, James E. , Eves, Neil D. ... - - Cancer - 2010

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-140803 , CALGB-9238

Phase II Study of Induction Cisplatin and Irinotecan Followed by Concurrent Carboplatin, Etoposide, and Thoracic Radiotherapy for Limited-Stage Small-Cell Lung Cancer, CALGB 30206

PubMed

PMC

QxMD

Google Scholar

Kelley, M. J. , Bogart, J. A. , Hodgson, L. D. , Ansari, R. H. ... - - J Thorac Oncol - 2013

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30206

CALGB 30206: Phase II study of induction cisplatin (P) and irinotecan (I) followed by combination carboplatin (C), etoposide (E), and thoracic radiotherapy for limited stage small cell lung cancer

Google Scholar

Kelley, M. J. , Bogart, J. A. , Hodgson, L. D. , Ansari, R. H. ... - - J. Clin. Oncol. - 2007

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30206

Factors impacting oncologic outcomes after sublobar pulmonary resection: Results from ACOSOG Z4032 (Alliance), a randomized trial for high-risk operable non-small cell lung cancer (NSCLC)

Google Scholar

Kent, M. , Landreneau, R. , Mandrekar, S. , Nichols, F. ... - ASCO - J. Clin. Oncol. - 2013

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

Impact of Sublobar Resection on Pulmonary Function: Long-term Results from ACOSOG Z4032 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Kent, Michael S. , Mandrekar, Sumithra J. , Landreneau, Rodney ... - - Ann. Thorac. Surg. - 2016

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective Study (ACOSOG Z4032)

PubMed

PMC

QxMD

DOI

Google Scholar

Kent, Michael S. , Mandrekar, Sumithra J. , Landreneau, Rodney ... - - Ann. Thorac. Surg. - 2016

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

Impact of Sublobar Resection on pulmonary function; Long-term results from Z4032 (Alliance), a randomized phase III trial

Google Scholar

Kent, Michael , Fernando, Hiran C , Mandrekar, Sumithra ... - STSA - Ann Thoracic Surg - 2016

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

Development of a Nomogram for Predicting Outcomes after Sublobar Resection for lung cancer; An Analysis from ACOSOG Z4032 (Alliance) a Randomized Trial

Google Scholar

Kent, Michael , Mandrekar, Sumithra , Landreneau, Rodney ... - AATS - - 2015

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

Association between cardiorespiratory fitness and overall survival in operable lung cancer patients: Ancillary analysis of protocol 9238

Google Scholar

Kohman, L. J. , Watson, D. M. , Herndon, J. E., 2nd , Eves, N. ... - - J. Clin. Oncol. - 2009

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-140803 , CALGB-9238

Surgeon Error In Predicting Stage I Non-Small Cell Lung Cancer (NSCLC) Is A Major Factor Precluding Randomization In CALGB 140503 (Alliance)

Google Scholar

Kohman, Leslie J. , Gu, Lin , Altorki, Nasser , Veit, Linda J. ... - AATS - - 2016

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-140503

Tolerability of veliparib (V) in combination with carboplatin (C)/paclitaxel (P) - based chemoradiotherapy (CRT) in subjects with stage III non-small cell lung cancer (NSCLC).

Google Scholar

Kozono, David E. , Salama, Joseph Kamel , Stinchcombe, Tom ... - ASCO - J. Clin. Oncol. - 2017

Abstract - Primary Endpoint - Primary Analysis - Respiratory - AFT-07

Veliparib (Vel) in Combination with Chemoradiotherapy (CRT) of Carboplatin/Paclitaxel (C/P) Plus Radiation in Patients With Stage III Non-Small Cell Lung Cancer (NSCLC) (AFT-07).

DOI

Google Scholar

Kozono, David E. , Stinchcombe, Thomas , Salama, Joseph K. ... - ASCO - J. Clin. Oncol. - 2019

Abstract - Primary Endpoint - Primary Analysis - Respiratory - AFT-07

Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?

PubMed

DOI

Google Scholar

Kozower, Benjamin D , Meyers, Bryan F , Reed, Carolyn E ... - - Ann. Thorac. Surg. - 2008

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0050

Response to the methylation inhibitor dihydro-5-azacytidine in mesothelioma is not associated with methylation of p16INK4a: results of cancer and leukemia group B 159904.

PubMed

DOI

Google Scholar

Kratzke, Robert A , Wang, Xiaofei , Wong, Long , Kratzke, Marian G ... - - J Thorac Oncol - 2008

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-159904

Phase II randomized trial of docetaxel plus cetuximab or bortezomib in patients with advanced NSCLC and performance status (PS) 2: CALGB 30402

Google Scholar

Lilenbaum, R. C. , Wang, X. , Gu, L. , Kirshner, J. ... - - J. Clin. Oncol. - 2007

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30402

A Phase II Study Of Induction Chemotherapy Followed By Thoracic Radiotherapy (TRT) And Erlotinib In Poor-risk Stage III Non-small Cell Lung Cancer (NSCLC): Initial Results Of CALGB 30605 And RTOG 0972

Google Scholar

Lilenbaum, R. , Samuels, M. , Kong, F. , Wang, X. , Janne, P. ... - - J Thorac Oncol - 2012

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30605

Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: The Cancer and Leukemia Group B (study 9730).

PubMed

DOI

Google Scholar

Lilenbaum, Rogerio C , Herndon, James E , List, Marcy A ... - - J. Clin. Oncol. - 2005

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9730

A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor risk stage III non-small cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)

PubMed

PMC

QxMD

DOI

Google Scholar

Lilenbaum, Rogerio , Samuels, Michael , Wang, Xiaofei ... - - J Thorac Oncol - 2015

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30605

Randomized Phase II Trial of Docetaxel Plus Cetuximab or Docetaxel Plus Bortezomib in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2: CALGB 30402

PubMed

PMC

QxMD

DOI

Google Scholar

Lilenbaum, Rogerio , Wang, Xiaofei , Gu, Lin , Kirshner, Jeffrey ... - - J Clin Oncol - 2009

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30402

Intraoperative sentinel node mapping with technitium-99 in lung cancer: results of CALGB 140203 multicenter phase II trial.

PubMed

DOI

Google Scholar

Liptay, Michael J , D'amico, Thomas A , Nwogu, Chumy , Demmy, Todd L ... - - J Thorac Oncol - 2009

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-140203

Preoperative exercise VO2 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238.

PubMed

DOI

Google Scholar

Loewen, Gregory M , Watson, Dorothy , Kohman, Leslie ... - - J Thorac Oncol - 2007

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9238

Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis.

PubMed

DOI

Google Scholar

Ma, Xiaoli , Le Teuff, Gwénaël , Lacas, Benjamin , Tsao, Ming Sound ... - - J Thorac Oncol - 2016

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-150802 , CALGB-9633

Comparison of progression-free survival (PFS) with best or confirmed response (BR, CR) as an endpoint for overall survival (OS) in advanced non small cell lung cancer (A-NSCLC): A North Central Cancer Treatment Group (NCCTG) investigation

Google Scholar

Mandrekar, S. J. , Hillman, S. L. , Ziegler, K. L. Allen ... - - J. Clin. Oncol. - 2008

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - N0424

Systematic evaluation of the impact of disease progression (DP) date determination on progression-free survival (PFS) in advanced lung cancer: a joint North Center Cancer Treatment Group (NCCTG) and Southwest Oncology Group (SWOG) investigation

Google Scholar

Mandrekar, S. J. , Qi, Y. , Allen-Ziegler, K. , Hillman, S. L. ... - - J. Clin. Oncol. - 2011

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - N0424

Impact of the Algorithm for Declaring Exact Progression Data on Progression-Free Survival Estimates in Advanced Lung Cancer

Google Scholar

Mandrekar, S. , Hillman, S. , Jatoi, A. , Jett, J. , Schild, S. ... - ASCO - J. Clin. Oncol. - 2010

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - N0424

Impact of disease progression (DP) date determination method on post progression survival (PPS) and DP metrics in advanced lung cancer

Google Scholar

Mandrekar, Sumithra J. , Foster, Nathan R. , Qi, Yingwei ... - ASCO - J. Clin. Oncol. - 2012

Abstract - No-Endpoint Endpoint - Comprehensive Analysis - Respiratory - N0424

Detection of Occult Micrometastases in Patients With Clinical Stage I Non–Small-Cell Lung Cancer: A Prospective Analysis of Mature Results of CALGB 9761 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Martin, Linda W. , D’Cunha, Jonathan , Wang, Xiaofei , Herzan, Debra ... - - J. Clin. Oncol - 2016

Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - C9761

A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531

PubMed

PMC

QxMD

DOI

Google Scholar

Masters, Gregory A. , Wang, Xiaofei , Hodgson, Lydia , Shea, Thomas ... - - Lung Cancer - 2011

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9531

Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' data

PubMed

PMC

QxMD

Google Scholar

Mauguen, A. , Pignon, J. P. , Burdett, S. , Domerg, C. , Fisher, D. ... - - Lancet Oncol. - 2013

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-8831 , CALGB-9310 , CALGB-9633 , NCCTG-892052 , NCCTG-902451 , NCCTG-942452

Exploring Therapeutic Decisions in Elderly Patients with Non-Small Cell Lung Cancer: Results and Conclusions from North Central Cancer Treatment Group Study N0222

PubMed

PMC

QxMD

DOI

Google Scholar

Mc Kean, Heidi , Stella, Philip J. , Hillman, Shauna L. ... - - Cancer Invest. - 2011

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - N0222

A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).

PubMed

Google Scholar

McClay, Edward F , Bogart, Jeff , Herndon, James E , Watson, Dee ... - - Am. J. Clin. Oncol. - 2005

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9235

The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.

PubMed

DOI

Google Scholar

Meyers, Bryan F , Downey, Robert J , Decker, Paul A ... - - J. Thorac. Cardiovasc. Surg. - 2007

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0060

Phase II trial of paclitaxel-topotecan-etoposide (PTE) followed by consolidation chemoradiotherapy for limited stage small cell lung cancer (LS-SCLC): CALGB 30002

Google Scholar

Miller, A. A. , Bogart, J. A. , Watson, D. M. , Wang, X. F. ... - - J. Clin. Oncol. - 2005

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30002

A Phase II Study of Dasatinib in Patients with Chemo-sensitive Relapsed Small Cell Lung Cancer (CALGB 30602)

Google Scholar

Miller, Antonius A. , Pang, Herbert , Hodgson, Lydia ... - - J Thorac Oncol - 2009

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30602

A Phase II Study of Dasatinib in Patients with Chemo-sensitive Relapsed Small Cell Lung Cancer (CALGB 30602)

PubMed

PMC

QxMD

DOI

Google Scholar

Miller, Antonius A. , Pang, Herbert , Hodgson, Lydia ... - - J Thorac Oncol - 2010

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30602

Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.

PubMed

DOI

Google Scholar

Miller, Antonius A , Wang, Xiaofei F , Bogart, Jeffrey A ... - - J Thorac Oncol - 2007

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30002

Phase II randomized study of dose-dense docetaxel and cisplatin every 2 weeks with pegfilgrastim and darbepoetin alfa with and without the chemoprotector BNP7787 in patients with advanced non-small cell lung cancer (CALGB 30303).

PubMed

DOI

Google Scholar

Miller, Antonius A , Wang, Xiaofei F , Gu, Lin , Hoffman, Philip ... - - J Thorac Oncol - 2008

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30303

A randomized phase II study of pemetrexed (PEM) with or without sorafenib (S) as second line therapy in advanced non-small cell lung cancer (NSCLC) of non-squamous histology: NCCTG N0626 study

Google Scholar

Molina, J. R. , Dy, G. K. , Foster, N. R. , Ziegler, Allen ... - ASCO - J. Clin. Oncol. - 2011

Abstract - Primary Endpoint - Primary Analysis - Respiratory - N0626

A randomized double-blinded phase II study of the Seneca Valley Virus (NTX-010) vs placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or responding after at least 4 cycles of platinum-based chemotherapy: NCCTG N0923 (Alliance) Study

Google Scholar

Molina, J. R. , Mandrekar, S. J. , Dy, G. , Aubry, M. C. ... - ASCO - J. Clin. Oncol. - 2013

Abstract - Primary Endpoint - Primary Analysis - Respiratory - N0923

A phase II study of the VEGFR inhibitor pazopanib (P) in patients with newly diagnosed or relapsed malignant pleural mesothelioma (MPM): an NCCTG study

Google Scholar

Molina, J. R. , Mandrekar, S. J. , Ziegler, K. L. Allen ... - - J Thorac Oncol - 2009

Abstract - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0623

NCCTG Phase II Trial (N0621) of the SRC inhibitor AZD0530 after 4 cycles of cytoreductive chemotherapy for patients with Extensive Stage Small Cell Lung Cancer (ED-SCLC)

Google Scholar

Molina, Julian R. , Foster, Nathan R. , Nelson, Garth D. ... - IASLC (WCLC) - J Thorac Oncol - 2009

Abstract - Primary Endpoint - Primary Analysis - Respiratory - N0621

A phase II trial of the Src-kinase inhibitor saracatinib after 4 cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621

PubMed

PMC

QxMD

DOI

Google Scholar

Molina, Julian R. , Foster, Nathan R. , Reungwetwattana, Thanyanan ... - - Lung Cancer - 2014

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0621

Randomized phase III intergroup trial of etoposide and cisplatin with or without paclitaxel and granulocyte colony-stimulating factor in patients with extensive-stage small-cell lung cancer: Cancer and Leukemia Group B Trial 9732.

PubMed

DOI

Google Scholar

Niell, Harvey B , Herndon, James E , Miller, Antonius A ... - - J. Clin. Oncol. - 2005

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - C9732

VATS Lobectomy Has Better Peri-operative Outcomes than Open Lobectomy: Ancillary Analysis of CALGB 140202 (Alliance)

Google Scholar

Nwogu, C. E. , D’cunha, J. , Pang, H. , Gu, L. , Wang, X. ... - STS - - 2014

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-140202

VATS Lobectomy Has Better Peri-operative Outcomes than open Lobectomy: CALGB 31001, an Ancillary Analysis of CALGB 140202 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Nwogu, Chukwumere E. , D’Cunha, Jonathan , Pang, Herbert , Gu, Lin ... - - Ann. Thorac. Surg. - 2015

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-140202 , CALGB-31001

A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.

PubMed

DOI

Google Scholar

Okuno, Scott H , Delaune, Robert , Sloan, Jeff A , Foster, Nathan R ... - - Cancer - 2008

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0021

Survival implications of variation in the thoroughness of pathologic lymph node examination in American College of Surgeons Oncology Group Z0030 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Osarogiagbon, Raymond U. , Decker, Paul A. , Ballman, Karla ... - - Ann. Thorac. Surg. - 2016

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Survival implications of variation in the lymph node (LN) count in ACOSOG Z0030 (Alliance)

Google Scholar

Osarogiagbon, Raymond U. , Decker, Paul , Ballman, Karla ... - IASLC (WCLC) - J Thorac Oncol - 2015

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Phase II Study of the HDAC Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (CALGB 30304)

PubMed

PMC

QxMD

DOI

Google Scholar

Otterson, G.A. , Hodgson, L. , Pang, H. ... - - J Thorac Oncol - 2010

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30304

Adjuvant targeted therapy following standard adjuvant therapy for resected NSCLC: An initial report from ALCHEMIST (Alliance A151216)

DOI

Google Scholar

Oxnard, Geoffrey R. , Mandrekar, Sumithra , Hillman, Shauna ... - IASLC (WCLC) - J Thorac Oncol - 2018

Abstract - Primary Endpoint - Preliminary Analysis - Respiratory - A151216

Validation of survival prognostic models for non-small-cell lung cancer instage- and age-specific groups

Google Scholar

Pang, H. , Gu, L. , Richards, W. , Crawford, J. , Green, M. , Vokes, E. ... - - Cancer Res. - 2013

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - Comprehensive

Validation of the CALGB and EORTC Prognostic Models for Mesothelioma Based on Multiple CALGB Trials (Alliance)

Google Scholar

Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance)

Google Scholar

Pang, Herbert , Yan, Kang , Kratzke, Robert , Stinchcombe, Thomas ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint Endpoint - Comprehensive Analysis - Respiratory - CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733

Updated analysis of a Phase III study of surgical resection and chemotherapy (paclitaxel/carboplatin) (CT) with or without adjuvant radiation therapy (RT) for resected stage III non-small cell lung cancer (NSCLC) CALGB 9734

Google Scholar

Perry, M. C. , Kohman, L. , Bonner, J. , Gu, L. , Wang, X. , Vokes, E. ... - - J. Clin. Oncol. - 2005

Abstract - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - CALGB-9734

A phase III study of surgical resection and paclitaxel/carboplatin chemotherapy with or without adjuvant radiation therapy for resected stage III non-small-cell lung cancer: Cancer and Leukemia Group B 9734.

PubMed

DOI

Google Scholar

Perry, Michael C , Kohman, Leslie J , Bonner, James A , Gu, Lin ... - - Clin Lung Cancer - 2007

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - C9734

LACE-Bio: Cross-validation and Pooled Analyses of the Putative Prognostic/Predictive Biomarkers p27, p16 and cyclin E in IALT, ANITA, JBR10 and CALGB 9633

Google Scholar

Pirker, R. , Rousseau, V. , Paris, E. , Tsao, M. S. , Aviel-Ronen, S. ... - - J Thorac Oncol - 2010

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

Incidence of bleeding and thrombosis among elderly patients undergoing systemic chemotherapy in advanced non-small cell lung cancer: An analysis of North Central Cancer Treatment Group trials

Google Scholar

Qi, Y. , Dy, G. K. , Nelson, G. D. , Schild, S. E. , Mandrekar, S. J. ... - ASCO - J. Clin. Oncol. - 2010

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - N0424

Pretreatment Quality of Life Is an Independent Prognostic Factor for Overall Survival in Patients with Advanced Stage Non-small Cell Lung Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Qi, Yingwei , Schild, Steven E. , Mandrekar, Sumithra J. ... - - J Thorac Oncol - 2009

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - N0424

A phase II study of cisplatin(C), irinotecan (I) and bevacizumab (B) for untreated extensive stage small cell lung cancer (ES-SCLC)

Google Scholar

Ready, N. E. , Dudek, A. Z. , Wang, X. , Graziano, S. L. ... - - J. Clin. Oncol. - 2007

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30306

Combination chemotherapy with sunitinib (IND 74019; NSC 736511) for untreated extensive stage small cell lung cancer (SCLC): CALGB 30504 phase IB safety results

Google Scholar

Ready, N. E. , Dunphy, F. R. , Pang, H. , Heinze, R. V. , Crawford, J. ... - - J. Clin. Oncol. - 2010

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30504

Chemotherapy with or without maintenance sunitinib for untreated extensive-stage small cell lung cancer: A randomized, placebo controlled phase II study CALGB 30504 (ALLIANCE)

Google Scholar

Ready, N. E. , Pang, H. H. , Gu, L. , Otterson, G. A. , Thomas, S. P. ... - ASCO - J. Clin. Oncol. - 2013

Abstract - Primary Endpoint - Primary Analysis - Respiratory - C30504

Cisplatin, Irinotecan, and Bevacizumab for Untreated Extensive-Stage Small-Cell Lung Cancer: CALGB 30306, a Phase II Study

PubMed

PMC

QxMD

DOI

Google Scholar

Ready, Neal E. , Dudek, Arkadiusz Z. , Pang, Herbert H. ... - - J Clin Oncol - 2011

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30306

Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Ready, Neal E. , Pang, Herbert H. , Gu, Lin , Otterson, Gregory A. ... - - J. Clin. Oncol - 2015

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30504

Chemoradiotherapy and gefitinib in stage III non-small cell lung cancer with epidermal growth factor receptor and KRAS mutation analysis: Cancer and Leukemia group B (CALGB) 30106, a CALGB-stratified phase II trial.

PubMed

DOI

Google Scholar

Ready, Neal , Jänne, Pasi A , Bogart, Jeffrey , Dipetrillo, Thomas ... - - J Thorac Oncol - 2010

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-150508 , CALGB-30106

Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials

PubMed

PMC

QxMD

Google Scholar

Reiman, T. , Lai, R. , Veillard, A. S. , Paris, E. , Soria, J. C. ... - - Ann. Oncol. - 2012

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

Prognostic value of Class III B-Tubulin (TUBB3) in operable non-small cell lung cancer (NSCLC) and predictive value for adjuvant cisplatin based chemotherapy (CT): A validation study on 3 randomized trials

Google Scholar

Reiman, T. , Seve, P. , Vataire, A. , Dunant, A. , Rosell, R. ... - - J. Clin. Oncol. - 2008

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-150802

Validation of the prognostic and predictive value of class III beta tubulin (TUBB3) for adjuvant chemotherapy (ACT) in completely resected non-small cell lung cancer (R-NSCLC): Results from four randomized trials

Google Scholar

Reiman, Tony , Seve, Pascal , Veillard, Anne-Sophie ... - IASLC (WCLC) - J Thorac Oncol - 2009

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

Brief report: a phase II "window-of-opportunity" frontline study of the MTOR inhibitor, temsirolimus given as a single agent in patients with advanced NSCLC, an NCCTG study.

PubMed

PMC

QxMD

DOI

Google Scholar

Reungwetwattana, Thanyanan , Molina, Julian R ... - - J Thorac Oncol - 2012

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0323

Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902.

PubMed

DOI

Google Scholar

Rocha-Lima, C M , Herndon, J E , Lee, M E , Atkins, J N , Mauer, A ... - - Ann. Oncol. - 2007

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39902

Comparison of performance status with peak oxygen consumption in operable patients with non-small-cell lung cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Roman, Michael A. , Koelwyn, Graeme J. , Eves, Neil D. ... - - Respirology - 2014

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9238

Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC

Google Scholar

Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Respiratory - AFT-16

CALGB 30103: A randomized phase II study of carboplatin and etoposide (CE) with or without G3139 in patients with extensive stage small cell lung cancer (ES-SCLC).

Google Scholar

Rudin, C. M. , Salgia, R. , Wang, X. F. , Green, M. R. ... - - J. Clin. Oncol. - 2005

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30103

Randomized Phase II Study of Carboplatin and Etoposide With or Without the bcl-2 Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103

PubMed

PMC

QxMD

DOI

Google Scholar

Rudin, Charles M. , Salgia, Ravi , Wang, Xiaofei , Hodgson, Lydia D. ... - - J. Clin. Oncol. - 2008

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30103

Occult Metastases in Lymph Nodes Predict Survival in Resectable Non–Small-Cell Lung Cancer: Report of the ACOSOG Z0040 Trial

PubMed

PMC

QxMD

Google Scholar

Rusch, V. W. , Hawes, D. , Decker, P. A. , Martin, S. E. , Abati, A. ... - - J. Clin. Oncol. - 2011

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0040

Predictors of pulmonary toxicity in limited stage (LS) small cell lung cancer (SCLC) patients treated with concurrent chemotherapy (CTX) and high dose (70 Gy) daily radiotherapy (RT), a pooled analysis of three CALGB studies

Google Scholar

Salama, J. K. , Hodgson, L. D. , Pang, H. , Green, M. R. ... - - J. Clin. Oncol. - 2011

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30002 , C30904 , CALGB-30206 , CALGB-30904 , CALGB-39808

A Pooled Analysis of Limited-Stage Small-Cell Lung Cancer Patients Treated with Induction Chemotherapy Followed by Concurrent Platinum-Based Chemotherapy and 70 Gy Daily Radiotherapy: CALGB 30904

PubMed

PMC

QxMD

Google Scholar

Salama, J. K. , Hodgson, L. , Pang, H. , Urbanic, J. J. ... - - J Thorac Oncol - 2013

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30904

Positive Interaction Between Prophylactic Cranial Irradiation And Maintenance Sunitinib For Untreated Extensive Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis Of CALGB 30504 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Salama, Joseph K. , Gu, Lin , Wang, Xiaofei , Pang, Herbert H. ... - - J Thorac Oncol - 2016

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-30504

Predictors of pulmonary toxicity in limited stage small cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904

PubMed

PMC

QxMD

Google Scholar

Salama, Joseph K. , Pang, Herbert , Bogart, Jeffery A. ... - - Lung Cancer - 2013

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-30904

Pulmonary toxicity in stage III non-small cell lung cancer patients treated with high dose (74 Gy) 3-dimensional conformal thoracic radiotherapy and concurrent chemotherapy following induction chemotherapy: A secondary analysis of Cancer and Leukemia Group B (CALGB) trial 30105

PubMed

PMC

QxMD

DOI

Google Scholar

Salama, Joseph K. , Stinchcombe, Thomas E. , Gu, Lin , Wang, Xiaofei ... - - Int J Radiat Oncol Biol Phys - 2011

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-30105

PCI Survival Improvement for Extensive Stage SCLC Limited to Patients on Maintenance Systemic Therapy: A Secondary Analysis of CALGB 30504 (Alliance)

Google Scholar

Salama, Josept K. , Gu, Lin , Wang, Xiaofei , Bogart, Jeffrey ... - IASLC (WCLC) - J Thorac Oncol - 2015

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-30504

A randomized double-blind phase II study of the Seneca Valley Virus (NTX-010) vs placebo for patients with extensive stage SCLC (ES-SCLC) who were stable or responding after at least 4 cycles of platinum-based chemotherapy: NCCTG (Alliance) N0923 Study.

PubMed

DOI

Google Scholar

Schenk, Erin L , Mandrekar, Sumithra J , Dy, Grace K ... - - J Thorac Oncol - 2019

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - N0923

N0321: A phase II study of bortezomib, paclitaxel, carboplatin, and radiotherapy for locally advanced non-small cell lung cancer

Google Scholar

Schild, S. E. , Molina, J. R. , Dy, G. K. , Rowland, K. M., Jr ... - - J. Clin. Oncol. - 2012

Abstract - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0321

Baseline quality of life (QOL) as a prognostic factor for overall survival (OS) in patients (Pts) with advanced stage non-small cell lung cancer (A-NSCLC): An analysis of NCCTG studies.

Google Scholar

Schild, S. E. , Qi, Y. , Tan, A. D. , Mandrekar, S. J. , Adjei, A. A. ... - - J. Clin. Oncol. - 2008

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - NCCTG-N0424

Prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC): Findings from a North Central Cancer Treatment Group (NCCTG) pooled analysis.

Google Scholar

Schild, S. , Foster, N. , Meyers, J. , Olivier, K. , Ross, H. ... - - J. Clin. Oncol. - 2011

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - NCCTG-89-20-51 , NCCTG-89-20-52 , NCCTG-892052 , NCCTG-95-20-53

Survival of patients (pts) treated with high-dose radiotherapy (RT) and concurrent chemotherapy for unresectable non-small cell lung cancer (NSCLC).

Google Scholar

Schild, S. , Graham, D. , Hillman, S. , Vora, S. , Yolanda, G. ... - - J. Clin. Oncol. - 2009

Abstract - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0028

Long-term Survival of Patients (pts) Treated with High-dose Radiotherapy(rt) and Concurrent Chemotherapy for Unresectable Non-small Cell Lung Cancer (nsclc)

Google Scholar

Schild, S. , Hillman, S. , Graham, D. , Vora, S. , Garces, Y. ... - MSTO - J Thorac Oncol - 2012

Abstract - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - NCCTG-N0028

The value of combined modality therapy in elderly patients with stage III non-small cell lung cancer (NSCLC)

Google Scholar

Schild, S. , Mandrekar, S. , Jatoi, A. , Mcginnis, W. , Stella, P. ... - - J. Clin. Oncol. - 2007

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - NCCTG-94-24-52 , NCCTG-90-24-51

N0321: A Phase I Study of bortezomib, Paclitaxel, Carboplatin (CBDCA) & Radiotherapy (RT) for Locally-Advanced Non-Small Cell Lung Cancer (NSCLC)

Google Scholar

Schild, S. , Molina, J. , Dy, G. , Rowland, K., Jr , Sarkaria, J. ... - - J. Clin. Oncol. - 2010

Abstract - Primary Endpoint - Preliminary Analysis - Respiratory - NCCTG-N0321

Long-terms results of a trial of concurrent chemotherapy and escalating doses of radiation for unresectable non–small cell lung cancer: NCCTG N0028 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Schild, Steven E. , Hillman, Shauna L. , Tan, Angelina D. ... - - J Thorac Oncol - 2017

Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - NCCTG-N0028

Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).

PubMed

DOI

Google Scholar

Schild, Steven E , Bonner, James A , Hillman, Shauna ... - - J. Clin. Oncol. - 2007

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-95-20-53

The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer.

PubMed

DOI

Google Scholar

Schild, Steven E , Mandrekar, Sumithra J , Jatoi, Aminah ... - - Cancer - 2007

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - NCCTG-90-24-51 , NCCTG-94-24-52

Results of a Phase I trial of concurrent chemotherapy and escalating doses of radiation for unresectable non-small-cell lung cancer.

PubMed

DOI

Google Scholar

Schild, Steven E , McGinnis, William L , Graham, David ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2006

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0028

Perioperative Outcomes of Video-Assisted (VATS) Lobectomy for Lung Cancer Compared to Open Thoracotomy and Lobectomy, An Analysis of Data from the American College of Surgeons Oncology Group (ACOSOG) Z0030 Clinical Trials

Google Scholar

Scott, W. J. , Allen, M. , Darling, G. , Meyers, B. F. , Decker, P. A. ... - WTSA - - 2009

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial.

PubMed

DOI

Google Scholar

Scott, Walter J , Allen, Mark S , Darling, Gail , Meyers, Bryan ... - - J. Thorac. Cardiovasc. Surg. - 2010

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Prognostic and Predictive Biomarkers for ACT (Adjuvant Chemotherapy) in Resected Non-Small Cell Lung Cancer (R-NSCLC): LACE-Bio

Google Scholar

Seymour, L. K. , Teuff, G. Le , Tsao, M. , Brambilla, E. ... - ESMO - Ann. Oncol. - 2014

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-150802 , CALGB-9633

LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer.

PubMed

DOI

Google Scholar

Seymour, Lesley , Le Teuff, Gwénaël , Brambilla, Elisabeth ... - - Clin Lung Cancer - 2019

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-9633

Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

PubMed

PMC

QxMD

Google Scholar

Shedden, K. , Taylor, J. M. , Enkemann, S. A. , Tsao, M. S. ... - - Nat. Med. - 2008

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - C9761 , C150302 , CALGB-9761

Prognostic and predictive effects of KRAS mutation subtype in completely resected non-small cell lung cancer (NSCLC): A LACE-bio study.

Google Scholar

Shepherd, F. A. , Bourredjem, A. , Brambilla, E. , Domerg, C. ... - - J. Clin. Oncol. - 2012

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

Pooled Analysis of the Prognostic and Predictive Effects of KRAS Mutation Status and KRAS Mutation Subtype in Early-Stage Resected Non–Small-Cell Lung Cancer in Four Trials of Adjuvant Chemotherapy

PubMed

PMC

QxMD

DOI

Google Scholar

Shepherd, Frances A. , Domerg, Caroline , Hainaut, Pierre ... - - J. Clin. Oncol - 2013

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

Cancer registries: a novel alternative to long-term clinical trial follow-up based on results of a comparative study

PubMed

PMC

QxMD

DOI

Google Scholar

Shi, Qian , You, Y Nancy , Nelson, Heidi , Allen, Mark S ... - - Clin Trials - 2010

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Calibration of quality-adjusted life years (QALYs) for oncology clinical trials (OCT)

Google Scholar

Sloan, J. , Novotny, P. , Sargent, D. , Decker, P. A. , Marks, R. ... - - J. Clin. Oncol. - 2010

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - NCCTG-89-20-52

Dosimetric evaluation of radiation exposure during I-125 vicryl mesh implants: implications for ACOSOG z4032.

PubMed

DOI

Google Scholar

Smith, Ryan P , Schuchert, Matthew , Komanduri, Krishna ... - - Ann. Surg. Oncol. - 2007

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4032

Sunitinib (S) switch maintenance in advanced non-small cell lung cancer (NSCLC): An ALLIANCE (CALGB 30607), randomized, placebo-controlled phase III trial.

Google Scholar

Socinski, Mark A. , Wang, Xiaofei F. , Baggstrom, Maria Quintos ... - ASCO - J. Clin. Oncol. - 2014

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30607

Switch Maintenance with Sunitinib (S) in Advanced Non-Small Cell Lung Cancer (NSCLC): An Alliance (CALGB 30607), Randomized, Placebo-controlled Phase III Trial

Google Scholar

Socinski, Mark A. , Wang, Xiaofei F. , Baggstrom, Maria Quintos ... - MSTO - Int. J. Radiat. Oncol. Biol. Phys. - 2014

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30607

Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105.

PubMed

DOI

Google Scholar

Socinski, Mark A , Blackstock, A William , Bogart, Jeffrey A ... - - J. Clin. Oncol. - 2008

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30105

A Pooled Analysis to the Prognosis and Predictive value of EGFR mutation on Survival in Patients with KRAS wild-type Lung Adenocarcinoma.

Google Scholar

Soria, Jean-Charles , Brambilla, Elisabeth , Le Teuff, Gwénaël ... - - J Thorac Oncol - 2011

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer

PubMed

PMC

QxMD

Google Scholar

Stinchcombe, T. E. , Hodgson, L. , Herndon, J. E. 2nd ... - - J Thorac Oncol - 2009

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - CALGB-39801

Clinical factors predictive of overall survival (OS) and the identification of prognostic groups in patients (pts) with unresectable stage III non-small cell lung cancer (NSCLC) treated with chemoradiotherapy on Cancer and Leukemia and Group B trial (CALGB) 39801

Google Scholar

Stinchcombe, T. E. , Hodgson, L. , Herndon, J. E., 2nd ... - - J. Clin. Oncol. - 2009

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-39801

An analysis of the prevalence of HER2 and KRAS mutations, and ALK rearrangements and clinical outcomes in Cancer and Leukemia Group B [CALGB (Alliance)] trial 30406 in advanced non-small cell lung cancer (NSCLC)

Google Scholar

Stinchcombe, T. E. , Sholl, L. M. , Wang, X. , Gu, L. ... - ASCO - J. Clin. Oncol. - 2013

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - C30406

Risk factors for distant recurrence and brain metastases observed on American College of Surgical Oncology Group trial Z0030: Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) Non- Small Cell Lung Cancer (NSCLC)

Google Scholar

Stinchcombe, Thomas E. , Decker, Paul A. , Darling, Gail E. ... - IASLC (WCLC) - J Thorac Oncol - 2009

Abstract - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Phase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B trial 9430

PubMed

PMC

QxMD

DOI

Google Scholar

Stinchcombe, Thomas E. , Mauer, Ann M. , Hodgson, Lydia D. ... - - J Thorac Oncol - 2008

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-9430

Adjuvant chemotherapy (AC) in stage IB non-small cell lung cancer (NSCLC): Long-term follow-up of Cancer and Leukemia Group B (CALGB) 9633

Google Scholar

Strauss, G. M. , Wang, X. , Maddaus, M. A. , Johnstone, D. W. ... - - J. Clin. Oncol. - 2011

Abstract - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - CALGB-9633

Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups

PubMed

PMC

QxMD

DOI

Google Scholar

Strauss, Gary M. , Herndon, James E. , Maddaus, Michael A. ... - - J Clin Oncol - 2008

Manuscript - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - CALGB-9633

Long-term surgical outcomes of 1018 patients with early stage NSCLC in ACOSOG Z0030 trial

Google Scholar

Su, S. , Scott, W. J. , Allen, M. S. , Darling, G. E. , Decker, P. A. ... - AATS - - 2013

Abstract - Primary Endpoint - Long-Term-Followup Analysis - Respiratory - CALGB-20502

Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (Alliance) trial

PubMed

PMC

QxMD

DOI

Google Scholar

Su, Stacey , Scott, Walter J , Allen, Mark S , Darling, Gail E ... - - J. Thorac. Cardiovasc. Surg. - 2014

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0030

Results of CALGB 39802: feasibility of video-assisted thoracic surgery (VATS) lobectomy for early stage lung cancer

Google Scholar

Swanson, S. J. , Herndon, J., 2nd , D'Amico, A. , Demmy, T. ... - - Proc Am Soc Clin Oncol - 2002

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39802

Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study.

PubMed

DOI

Google Scholar

Swanson, Scott J , Herndon, James E , D'Amico, Thomas A ... - - J. Clin. Oncol. - 2007

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39802

LACE-Bio Pooled Analysis of the Prognostic and Predictive Value of KRAS Mutation in Completely Resected Non-Small Cell Lung Cancer (NSCLC)

Google Scholar

Tsao, M. S. , Hainaut, P. , Bourredjem, A. , Janne, P. A. ... - - Ann. Oncol. - 2010

Abstract - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - CALGB-9633

PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Tsao, M.-S. , Le Teuff, G. , Shepherd, F. A. , Landais, C. ... - - Ann. Oncol - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

PubMed

PMC

QxMD

DOI

Google Scholar

Tsao, Ming-Sound , Marguet, Sophie , Le Teuff, Gwénaël ... - - J. Clin. Oncol - 2015

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - CALGB-9633

Phase I Study of Accelerated Hypofractionated Radiotherapy with Concurrent Chemotherapy for Stage III Non-Small-Cell Lung Cancer: CALGB 31102 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Urbanic, James J. , Wang, Xiaofei , Bogart, Jeffrey A. ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2018

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-31102

Phase I Study of Accelerated Hypofractionated Radiotherapy with Concurrent Chemotherapy for Stage III Non-Small-Cell Lung Cancer: CALGB 31102 (Alliance)

Google Scholar

Urbanic, James J , Bogart, Jeffrey A , Stinchcombe, Thomas ... - ASTRO - Int. J. Radiat. Oncol. Biol. Phys. - 2015

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-31102

Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial.

PubMed

DOI

Google Scholar

Veeramachaneni, Nirmal K , Zoole, Jennifer B , Decker, Paul A ... - - Ann. Thorac. Surg. - 2008

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z0060

Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B.

PubMed

DOI

Google Scholar

Vokes, Everett E , Herndon, James E , Kelley, Michael J ... - - J. Clin. Oncol. - 2007

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - CALGB-39801

A Phase II Study of Carboplatin, Etoposide and Exisulind in Patients with Extensive Stage Small Cell Lung Cancer: CALGB 30104

Google Scholar

Wang, X. F. , Govindan, R. , Herndon, J. E., 2nd , Barrier, R. C. ... - - J. Clin. Oncol. - 2005

Abstract - Primary Endpoint - Primary Analysis - Respiratory - CALGB-30104

Validation of Survival Prognostic Models for Non-Small-Cell Lung Cancer in Stage- and Age-specific Groups

PubMed

PMC

QxMD

DOI

Google Scholar

Wang, Xiaofei , Gu, Lin , Zhang, Ying , Sargent, Daniel J. ... - - Lung Cancer - 2015

Manuscript - Secondary-not-in-original Endpoint - Comprehensive Analysis - Respiratory - C8834 , C8836 , C8931 , C8932 , C9132 , C9532 , CALGB-140202 , CALGB-140203 , CALGB-30203 , CALGB-30303 , CALGB-30402 , CALGB-30406 , CALGB-30506 , CALGB-30704 , CALGB-39802 , CALGB-39809 , CALGB-39904 , CALGB-9238 , CALGB-9335 , CALGB-9633 , CALGB-9730 , CALGB-9731 , CALGB-9761 , Comprehensive

Validation of Progression‐Free Survival as a Surrogate Endpoint for Overall Survival in Malignant Mesothelioma: Analysis of Cancer and Leukemia Group B and North Central Cancer Treatment Group (Alliance) Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Wang, Xiaofei , Wang, Xiaoyi , Hodgson, Lydia , George, Stephen L. ... - - Oncologist - 2017

Manuscript - Secondary-not-in-original Endpoint - Primary Analysis - Respiratory - C8435 , C8638 , C8833 , C8933 , C9031 , CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733 , N0021 , NCCTG-N0623

Morphological Appearance of Radiofrequency Ablated Stage IA NSCLC in Medically Inoperable Patients as Related to Recurrence: Results from the ACOSOG Z4033 (Alliance Trial)

Google Scholar

Xiong, Lillian , Alexander, Erica , Hillman, Shauna , Tan, Angelina ... - RSNA - - 2015

Abstract - Secondary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4033

Radiofrequency Ablation of Medically Inoperable Stage IA Non–Small Cell Lung Cancer: Are Early Posttreatment PET Findings Predictive of Treatment Outcome?

PubMed

PMC

QxMD

DOI

Google Scholar

Yoo, Don C. , Dupuy, Damian E. , Hillman, Shauna L. ... - - AJR Am J Roentgenol - 2011

Manuscript - Secondary Endpoint - Primary Analysis - Respiratory - ACOSOG-Z4033

A Phase I/II Study of Bortezomib in Combination with Paclitaxel, Carboplatin and Concurrent Thoracic Radiation Therapy for Non-Small Cell Lung Cancer: NCCTG-N0321

PubMed

PMC

QxMD

DOI

Google Scholar

Zhao, Yujie , Foster, Nathan R. , Meyers, Jeffrey P. ... - - J Thorac Oncol - 2015

Manuscript - Primary Endpoint - Primary Analysis - Respiratory - NCCTG-N0321